Articles · Symptoms

Hormonal Migraines in Perimenopause: Why They Happen

How swinging estrogen can worsen attacks, and why postmenopause often brings relief.

5 min read · Published May 30, 2026 · Updated September 29, 2026

Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.

Hormonal Migraines in Perimenopause: Why They Happen

Migraine is three times more common in women than men, and the gap is widest during the reproductive years. Estrogen directly affects the trigeminovascular system and the brain’s pain pathways in ways that make migraine attacks more likely when estrogen levels change fast.

Perimenopause is often the worst stretch for migraine in a woman’s life. For women who have had migraines since their teens, attacks may become more frequent, longer, and harder to treat. Some women get migraines for the first time during perimenopause. Understanding why this happens also explains the path that follows.

The Swing, Not the Level, Is the Trigger

Research on migraine during the transition has found that attacks are driven by the rate of estrogen change, not by the absolute estrogen level.[1]

Women with migraines did not have consistently higher or lower estrogen than those without. What differed was how fast estrogen fell in the late luteal phase of each cycle. This fits the estrogen withdrawal idea: migraine attacks are triggered when estrogen falls below about 45 to 50 pg/mL after a sustained stretch of higher levels.[2]

During perimenopause, estrogen becomes unpredictably erratic. It can surge well above the premenopausal baseline one week and drop sharply the next. These fast swings create repeated withdrawal triggers through the month, wherever a woman is in her cycle. Women who previously had migraine only at menstruation may find it happening at other times for this reason.

What Happens After Menopause

Once estrogen settles at a consistently low level after the final period, the swings that trigger withdrawal migraines are reduced. Studies consistently show that women with migraine without aura often see improvement in frequency and severity in the postmenopausal years.[3] The erratic hormone environment resolves, and the withdrawal trigger with it.

Women with migraine with aura have a more complex picture. Their migraines may also improve, but they carry double the risk of ischaemic stroke, independent of other risk factors.[4] This background risk shapes the risk-and-benefit balance for HRT.

Managing Migraines During Perimenopause

Transdermal estradiol. For women whose migraines are tied to estrogen swings, steadying levels with continuous transdermal estradiol can reduce attack frequency. Oral estrogen creates peaks and troughs with each dose and tends to worsen hormone-triggered migraines. Transdermal delivery (patches, gels) gives more stable levels and is the recommended route when HRT is considered for migraine.[3][5]

The key principle: continuous dosing without hormone-free gaps prevents the withdrawal events that trigger attacks.

Migraine with aura and HRT. Migraine with aura does not absolutely rule out physiological doses of transdermal estradiol, unlike the combined pill, where ethinylestradiol clearly raises stroke risk.[4] But HRT users who have an increase in migraine severity, including more frequent aura, show higher odds of ischaemic stroke, and the decision needs careful individual risk assessment.[5]

Acute treatment. Perimenopausal migraines tend to be longer and more resistant to treatment than episodic attacks. Triptans are the most evidence-backed acute option. Long-acting triptans (frovatriptan, naratriptan) are useful for preventing predictable hormone-related attacks, because they can be started before the expected withdrawal window.[3]

Preventive medication. For women with frequent attacks that impair function, migraine preventives (beta-blockers, topiramate, amitriptyline, or CGRP monoclonal antibodies) are appropriate. These work independent of hormonal management and can be used alongside or instead of hormonal approaches.

When a Changing Migraine Pattern Needs Assessment

A headache that has changed in character, frequency, or location deserves clinical attention, not the assumption that it is the same migraine as before. A new severe headache in midlife, especially if it is different from previous headaches or comes with neurological symptoms, should be assessed rather than put down to hormonal change.

For most women, the path follows a pattern: perimenopause worsens the frequency and severity of hormone-driven migraine, and postmenopause brings gradual improvement. The years in between are the stretch that most warrants active management.

Frequently Asked Questions

Can perimenopause make migraines worse?

Yes, for most women who already get migraines. The trigger is the speed of estrogen’s swings during perimenopause, not the level itself, which is why attacks often become more frequent and harder to treat through the transition.[1][2] Once hormones settle at a stable low level after menopause, studies consistently show migraine without aura improving in frequency and severity for most women.[3]


References

[1] Aegidius, K. L., Zwart, J. A., Hagen, K., Schei, B., Stovner, L. J. (2007). Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. European Journal of Neurology, 14(1), 73-78. See also: Migraine during perimenopause. https://pmc.ncbi.nlm.nih.gov/articles/PMC4759136/

[2] MacGregor, E. A. (2023). Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence. Cephalalgia, 43(10). https://pmc.ncbi.nlm.nih.gov/articles/PMC10512516/

[3] Pavlović, J. M. (2021). Menstrual and perimenopausal migraine: A narrative review. Headache, 60(10). https://pubmed.ncbi.nlm.nih.gov/33158484/

[4] Kurth, T., Schürks, M., Logroscino, G., Gaziano, J. M., Buring, J. E. (2010). Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ, 341, c3621. See also: Migraine with aura and stroke risk. https://pmc.ncbi.nlm.nih.gov/articles/PMC7948327/

[5] MacGregor, E. A. (2018). Migraine, menopause and hormone replacement therapy. Post Reproductive Health, 24(1), 11-18. https://pubmed.ncbi.nlm.nih.gov/28994639/

Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.